hydroxypropyl-gamma-cyclodextrin has been researched along with vancomycin in 1 studies
| Studies (hydroxypropyl-gamma-cyclodextrin) | Trials (hydroxypropyl-gamma-cyclodextrin) | Recent Studies (post-2010) (hydroxypropyl-gamma-cyclodextrin) | Studies (vancomycin) | Trials (vancomycin) | Recent Studies (post-2010) (vancomycin) |
|---|---|---|---|---|---|
| 86 | 0 | 34 | 16,808 | 773 | 7,589 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biesse-Martin, AS; Bouattour, Y; Chennell, P; Frederic, R; Jouannet, M; Neflot-Bissuel, F; Sautou, V; Traïkia, M; Wasiak, M; Yessaad, M | 1 |
1 other study(ies) available for hydroxypropyl-gamma-cyclodextrin and vancomycin
| Article | Year |
|---|---|
Cyclodextrins Allow the Combination of Incompatible Vancomycin and Ceftazidime into an Ophthalmic Formulation for the Treatment of Bacterial Keratitis.
Topics: Anti-Bacterial Agents; Ceftazidime; Drug Compounding; Eye Infections, Bacterial; gamma-Cyclodextrins; Humans; Keratitis; Vancomycin | 2021 |